In partnership with King County Public Health and the Seattle Chamber, we will be sharing biweekly updates on the status of vaccine distribution. For real-time information, please click here >
Vaccine Rollout Update
King County is working hard to rapidly vaccinate the 1.8 million adults who live in our region, starting with those at highest risk, with a goal of reaching 70%, or 1.26 million people with two doses of vaccine (the two currently approved COVID-19 vaccines currently are two-dose vaccines), by the end of summer.
The weather impacted testing appointments and vaccine deliveries for this week so the data from King County will likely lag a bit in the coming week. As of the data collected last week, nearly 70 percent of the county’s licensed health care workers have received at least one dose of a vaccine (a 10% increase from the previous week) and there are now 13 mobile teams in the field in King County. Those teams are focused on vaccinating vulnerable populations in senior living facilities and adult family homes.
The biggest constraint remains short supply from the manufacturers and the federal government. This week is a particular challenge as the supply from the state is focused on second doses and supplies are further limited due to weather impacts nationally for vaccine delivery to our state. While supply remains a constraint currently, the systems are being put in place so that when supply increases all those who are eligible will be able to quickly get vaccinated.
These efforts will grow with the vaccine supply, in partnership with many business and health care providers across the county. You can read King County’s Unified Regional Strategy COVID Vaccine Delivery and stay up to date with weekly strategy updates.
What Is in the Vaccine?
Fred Hutch behavioral scientist and pharmacist Dr. Parth Shah says “The ingredients list in these vaccines is probably shorter than the list of ingredients in a bag of chips”.
Facts and Myths
Assistant Professor of Pediatrics at Dell Medical School Dr. Ana Avalos debunks misconceptions surrounding the currently approved COVID-19 vaccines in the United States.